Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
To get information on pharmaceutical patents
— Business development, China
To analyze generic candidates using patent expiration data
— Portfolio management, Indonesia
To proactively manage the hospital's pharmaceutical inventory
— Hospital pharmacist, USA
To conduct drug patent landscape analysis
— Pharmaceutical R&D, China
To gain knowledge on formulations of different drugs
— Product development officer, Pharmaceutical company, Bangladesh
Generated: May 27, 2017
What are the generic sources for plerixafor and what is the scope of plerixafor patent protection?
Plerixafor is the generic ingredient in one branded drug marketed by Genzyme and is included in one NDA. There are three patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.| Tradenames: | 1 |
| Patents: | 3 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Master File Entries: see list | 4 |
| Suppliers / Packagers: see list | 2 |
| Bulk Api Vendors: see list | 65 |
| Clinical Trials: see list | 88 |
| Patent Applications: see list | 1,131 |
| Drug Prices: | see low prices |
| DailyMed Link: | plerixafor at DailyMed |
| Drug Class | Hematopoietic Stem Cell Mobilizer |
| Physiological Effect | Increased Hematopoietic Stem Cell Mobilization |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Genzyme | MOZOBIL | plerixafor | SOLUTION;SUBCUTANEOUS | 022311-001 | Dec 15, 2008 | RX | Yes | Yes | RE42152 | ► Subscribe | Y | ► Subscribe | |||||||||||||||||
Genzyme | MOZOBIL | plerixafor | SOLUTION;SUBCUTANEOUS | 022311-001 | Dec 15, 2008 | RX | Yes | Yes | 7,897,590 | ► Subscribe | ► Subscribe | ||||||||||||||||||
Genzyme | MOZOBIL | plerixafor | SOLUTION;SUBCUTANEOUS | 022311-001 | Dec 15, 2008 | RX | Yes | Yes | 6,987,102 | ► Subscribe | ► Subscribe | ||||||||||||||||||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
Expired Orange Book Patents
Available with subscription
Paragraph IV Activity
Available with subscription
Patent Maintenance
Available with subscription
Non-Orange Book Patents
Available with subscription
International Patents
Available with subscription
Supplementary Protection Certificates
Available with subscription
To find out patent expiration data for the Czech Republic
— Doctor, Czech Republic
To get information on drug patent expirations
— Analyst, USA
information on patent expiries and potential generic entrants
— Consultant, USA
To track filing and history of various APIs
— API research and development, USA
To find generic producers around the world for specific active ingredients.
— Pharmaceutical wholesaler, Estonia
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639
Follow DrugPatentWatch:
